Sign up
Log in
MARKET
ERNA
ERNA
Eterna Therapeutics Inc
NASDAQ
1.810
+0.010
+0.56%
After Hours: 1.810 0 0.00% 17:11 07/26 EDT
OPEN
1.800
PREV CLOSE
1.800
HIGH
1.850
LOW
1.760
VOLUME
4.10K
TURNOVER
0
52 WEEK HIGH
2.960
52 WEEK LOW
0.8401
MARKET CAP
9.79M
P/E (TTM)
-0.4257
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ERNA last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at ERNA last week (0708-0712)?
Weekly Report · 07/15 10:19
Weekly Report: what happened at ERNA last week (0701-0705)?
Weekly Report · 07/08 10:19
Weekly Report: what happened at ERNA last week (0624-0628)?
Weekly Report · 07/01 10:20
Weekly Report: what happened at ERNA last week (0617-0621)?
Weekly Report · 06/24 10:24
Weekly Report: what happened at ERNA last week (0610-0614)?
Weekly Report · 06/17 10:19
Weekly Report: what happened at ERNA last week (0603-0607)?
Weekly Report · 06/10 10:20
12 Health Care Stocks Moving In Monday's Intraday Session
Structure Therapeutics stock moved upwards by 71.0% to $58.47 during Monday's regular session. Concord Medical Services stock rose 55.96% during the session. Other gainers include Microbot Medical (NASDAQ:MBOT) and Olema Pharmaceuticals. Losers include CNS Pharma and Galera Therapeutic.
Benzinga · 06/03 16:31
About ERNA
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.
Webull offers Eterna Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.